Piper Sandler Maintains Neutral on Elanco Animal Health, Lowers Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Westenberg maintains a Neutral rating on Elanco Animal Health (NYSE:ELAN) and lowers the price target from $19 to $16.
July 01, 2024 | 10:49 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Piper Sandler analyst David Westenberg maintains a Neutral rating on Elanco Animal Health and lowers the price target from $19 to $16.
The lowered price target from $19 to $16 by Piper Sandler suggests a less optimistic outlook for Elanco Animal Health, which could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100